Advertisement

Verax Biomedical Inc., a Worcester medical products developer, has raised $1.3 million in an equity funding filed with the U.S. Securities and Exchange Commission today.

In the regulatory filing, the privately held company does not detail the investors behind the funding, but in its list of related persons, it includes board members Buzz Benson, founding member of SightLine Partners; Joe Del Guercio, managing director at CNF Investments LLC; Marc Goldberg, general partner at BioVentures Investors; Robert Zieserl, managing director of KB Partners; and James Koziarz, previously a corporate vice president at Abbott Laboratories.

SOURCE

Advertisement
Advertisement